$112 million settlement: charged with kickbacks from drug company & recommending docs prescribe antipsychotic drug Risperdal

The U.S. Justice Department said that Johnson & Johnson’s kickbacks to Omnicare, the largest U.S. provider of pharmacy services to nursing homes, took multiple forms, including rebates that were conditioned on Omnicare engaging in an ‘Active Intervention Program’ for Risperdal and payments disguised as data purchase fees, educational grants, and fees to attend Omnicare meetings.

Psychiatrist exposed in Grassley investigation resigns after failing to report hundreds of thousands in Pharma funds

Charles Nemeroff, who failed to disclose to Emory University approximately $800,000 in payments he received from drug maker GlaxoSmithKline (GSK) while he was the principal investigator (PI) on a multi-million dollar grant from the NIH to study five GSK antidepressants, is leaving the university.

Dr. Peter Breggin: Antipsychotic Drugs, Their Harmful Effects, and the Limits of Tort Reform

Ironically, the FDA is approving these drugs for use in children at the same time that the Justice Department has been fining drug companies for illegally marketing these drugs to children. The illegal marketing corrupted and contaminated medical practice, encouraging physicians to prescribe off label, eventually leading the FDA to then approve off label prescribing. The studies used to justify this approval have been wholly developed and supervised by these same drugs companies using handpicked doctors who have often been involved in encouraging off label use. Drug companies commonly ghostwrite the research publications that appear under the names of these doctors.

In UK, Doctors under fire as an alarming numbers of children are given drugs to combat depression and ADHD

Shadow Health Minister Anne Milton said doctors should be opting for non-drug treatments rather than reaching for the prescription pad. ‘This data shows that increasingly health professionals are prescribing drugs to treat child mental health problems, when evidence suggests that talking therapies can have an equal, if not better effect.

New book Anatomy of an Epidemic – psychiatric drug-based paradigm fuels epidemic of “mental illness”

A review of the scientific literature reveals that it is our drug-based paradigm of care that is fueling this epidemic. The drugs increase the likelihood that a person will become chronically ill, and induce new and more severe psychiatric symptoms in a significant percentage of patients.

CCHR International

News